PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel |
|
|
| Completed | 3 | 571 | Europe, Canada, US, RoW | NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel | NovoCure Ltd. | Pancreas Adenocarcinoma | 10/24 | 10/24 | | |
NCT04247126: A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors |
|
|
| Completed | 1 | 105 | US | SY-5609, Fulvestrant, Gemcitabine, Nab-paclitaxel | Syros Pharmaceuticals | Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer, Pancreatic Cancer | 01/23 | 03/23 | | |
BASECAMP-1, NCT04981119: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
|
|
| Recruiting | N/A | 200 | US | Apheresis, Next Generation Sequencing (NGS), Long Range NGS HLA typing | A2 Biotherapeutics Inc., Tempus AI | Solid Tumor, Adult, Colorectal Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, CRC, NSCLC, Pancreas Cancer, Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Mesothelioma, Malignant, Mesothelioma; Lung, Cancer | 12/25 | 12/26 | | |
